News
News

The latest updates from AFAR.

Grantee in the News: Reisa Sperling to lead new Alzheimer’s Clinical Trial Consortium with $70mill NIH grant

Dec 14
2017

Grantee in the News: Reisa Sperling to lead new Alzheimer’s Clinical Trial Consortium with $70mill NIH grant View MoreBACK

As part of a team of three physician-scientists, 2003 Beeson Scholar Reisa Sperling, MD, MMSc, has been awarded a $70 million dollar award from the National Institutes of Health (NIH) to launch the Alzheimer’s Clinical Trials Consortium (ACTC).

The Alzheimer’s Clinical Trials Consortium will create a network of 35 Alzheimer’s disease trial sites across the country with the goal of finding new ways to treat or prevent the illness.

Dr. Sperling tells the Harvard Gazette:

“We must overhaul our current recruitment strategies for clinical trials, particularly to improve the diversity of our study participants and to reach people who do not yet have symptoms of Alzheimer’s disease for inclusion in future prevention trials,” said Sperling, who is the principal investigator of the ACTC at both Harvard-affiliated BWH and Massachusetts General Hospital. “The new ACTC presents a terrific opportunity to innovate in recruitment, cognitive assessments, and neuroimaging for the next generation of Alzheimer’s trials."

Dr. Sperling will collaborate will collaborate with Ronald C. Petersen at the Mayo Clinic and Paul Stephen Aisen at the Keck School of Medicine at the University of Southern California (USC) to accelerate clinical trials for Alzheimer’s and related dementias.

For more, read the Harvard Gazette story here.


Reisa Sperling, MD, MMSc, is the Director of the Center for Alzheimer's Research and Treatment & Co-Director, Neuroimaging Core at the Massachusetts Alzheimer's Disease Research Center; a Professor of Neurology, Harvard Medical School; and Director of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital (BWH).





View MoreBACK TO TOP